Health
Reducing COVID-19 burden with monoclonal antibodies and vaccination – News-Medical.Net
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress…
Researchers in the United States, the UK and France have shown that using antiviral monoclonal antibodies in combination with vaccination can be expected to suppress the transmission of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and reduce the burden of coronavirus disease 2019 (COVID-19) more than vaccination alone.
The team’s modeling simulations suggested that the near-term use of monoclonal antibodies (mAbs) for early treatment and post-exposure prophylaxis (PEP) in combination…
-
Noosa News13 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General23 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Business22 hours agoRevenue growth, profit margin pressures, and a $365m buyback
-
Noosa News24 hours agoUrgent recall notice issued for deli meats over contamination risk